Neurotoxicity of cisplatin and taxol
Open Access
- 1 April 1995
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 5 (3) , 161-169
- https://doi.org/10.1046/j.1525-1438.1995.05030161.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Nerve growth factor prevents toxic neuropathy in miceAnnals of Neurology, 1991
- Cisplatin induced neuropathy: Central, peripheral and autonomic nerve involvementJournal of Neuro-Oncology, 1990
- Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatinCancer, 1990
- Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle crampsCancer, 1990
- Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerCancer Chemotherapy and Pharmacology, 1990
- Progressive paresthesias after cessation of therapy with very high-dose cisplatinCancer Chemotherapy and Pharmacology, 1989
- Transient blindness and seizure associated with cisplantin therapyZeitschrift für Krebsforschung und Klinische Onkologie, 1988
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studiesCancer, 1984
- Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old manCancer, 1980